Close

Eli Lilly & Co. (LLY), Adocia Initiate BioChaperone Lispro Phase 1b

August 27, 2015 6:15 AM EDT Send to a Friend
Eli Lilly & Co. (NYSE: LLY) and Adocia announced the initiation of a Phase 1b clinical trial evaluating BioChaperone Lispro ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login